AI-generated summary
The authors retrospectively reviewed 49 pediatric patients who received allogeneic stem cell transplants and were given professional dental care and photobiomodulation as prevention. They report that oral mucositis developed in 73.5% of patients, with 36.1% classified as severe. Acute lymphoblastic leukemia and myeloablative conditioning were associated with mucositis development, and myeloablative conditioning and high body mass index were associated with lower oral mucositis-free survival.
- Participants
- 49
- Who or what was studied
- Pediatric patients younger than 18 years with hematological cancer who underwent allogeneic hematopoietic stem cell transplantation between 2013 and 2016
- Limits stated in the abstract
- The study was retrospective and single-group, with no control group receiving no photobiomodulation, and the abstract does not report a wavelength for the photobiomodulation used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Traumatic brain injury. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.